New Zealand markets closed

Ventyx Biosciences, Inc. (VTYX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.7300-0.2500 (-5.02%)
At close: 04:00PM EDT
4.7800 +0.05 (+1.06%)
After hours: 07:01PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-192,603
-192,962
-108,426
-83,746
-28,174
Depreciation & amortisation
1,215
941
470
30
0
Stock-based compensation
28,564
28,588
16,570
2,730
45
Change in working capital
-11,551
5,806
-5,157
4,016
811
Accounts payable
-1,844
-745
1,613
2,443
591
Other working capital
-183,855
-167,036
-99,046
-38,912
-6,195
Other non-cash items
-
-
-
27,269
21,123
Net cash provided by operating activities
-183,226
-166,522
-98,771
-38,650
-6,195
Cash flows from investing activities
Investments in property, plant and equipment
-629
-514
-275
-262
-
Purchases of investments
-188,886
-272,271
-347,236
-232,502
0
Sales/maturities of investments
351,115
373,725
272,580
16,500
0
Net cash used for investing activities
161,600
100,940
-74,931
-214,365
0
Cash flows from financing activities
Common stock issued
96,045
48,408
165,398
158,815
0
Net cash used provided by (used for) financing activities
100,867
53,329
167,772
323,551
6,130
Net change in cash
79,204
-12,265
-5,972
70,547
-65
Cash at beginning of period
63,669
64,819
70,791
244
309
Cash at end of period
142,910
52,554
64,819
70,791
244
Free cash flow
Operating cash flow
-183,226
-166,522
-98,771
-38,650
-6,195
Capital expenditure
-629
-514
-275
-262
-
Free cash flow
-183,855
-167,036
-99,046
-38,912
-6,195